Evaluation of the Efficacy of Different Non-Surgical Peri-implantitis Treatment Approaches
NCT ID: NCT06849856
Last Updated: 2025-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2024-02-15
2025-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Biochemical Evaluation of the Efficacy of Non-Surgical Treatment Approaches in the Treatment of Peri-implantitis
NCT05201443
Effect of Different Non-surgical Treatment Approaches of Peri-implantitis
NCT06730568
Non-Surgical Treatment of Peri-Implantitis With Ultrasonic Carbon Tip
NCT06514677
Reconstructive Surgical Therapy of Peri-implantitis
NCT04769609
Peri-implantitis Treatment With Chitosan Brush
NCT06830200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment of peri-implantitis using titanium curette
Non-surgical peri-implantitis treatment will be performed using titanium curettes suitable for use on implant surfaces
non-surgical peri-implantitis therapy with titanium curette
Titanium curette will be used for non-surgical treatment of peri-implantitis
Treatment of peri-implantitis using Airflow device
Non-surgical peri-implantitis treatment will be performed using erythritol powder with Airflow device
non-surgical peri-implantitis therapy with airflow device
Airflow device with erythritol powder will be used in the treatment of non-surgical peri-implantitis
Treatment of peri-implantitis using titanium curette + Airflow device
Non-surgical peri-implantitis treatment will be performed using titanium curette and erythritol powder with Airflow device
non-surgical peri-implantitis therapy with airflow device
Airflow device with erythritol powder will be used in the treatment of non-surgical peri-implantitis
non-surgical peri-implantitis therapy with titanium curette
Titanium curette will be used for non-surgical treatment of peri-implantitis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-surgical peri-implantitis therapy with airflow device
Airflow device with erythritol powder will be used in the treatment of non-surgical peri-implantitis
non-surgical peri-implantitis therapy with titanium curette
Titanium curette will be used for non-surgical treatment of peri-implantitis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Who have not used any medication (antibiotics, anti-inflammatory drugs, antibacterial mouthwashes, corticosteroids) that could affect the results of the study in the last 3 months,
3. Who have at least one implant with a probing depth of 6 mm or deeper in one or more areas in the mouth, and the implant in question has been in function for at least 1 year,
4. Between the ages of 18-65,
5. Individuals who approve the informed consent form will be included in the study.
Exclusion Criteria
1. have a systemic disease that may affect the periodontium,
2. regularly use medication that may affect the periodontium,
3. smoke,
4. are pregnant or lactating,
5. are sensitive to chlorhexidine,
6. have more than 50% bone loss around their current implant(s),
7. do not approve the informed consent form will be excluded from the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meltem Ozdemir Kabalak
Instructor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THD-2023-20873
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.